Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Alexander Åkesson, James B. Bussel, Myriam Martin, Anna M. Blom, Jenny Klintman, Waleed Ghanima, Eva Zetterberg & Lamya Garabet. (2023) Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study. Platelets 34:1.
Read now
Read now
Yan-ming Wang, Ya-fei Yu, Yu Liu, Shuang Liu, Ming Hou & Xin-guang Liu. (2020) The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia. Hematology 25:1, pages 139-144.
Read now
Read now
Anne Gulbech Ording, Nickolaj Risbo Kristensen, Henrik Frederiksen, Naufil Alam, Shahram Bahmanyar, Waleed Ghanima, Mette Nørgaard & Christian Fynbo Christiansen. (2019) Routine clinical care for chronic immune thrombocytopenia purpura in Denmark, 2009–2015. Hematology 24:1, pages 732-736.
Read now
Read now
Articles from other publishers (37)
Dong-mei Yin, Dai Yuan, Rui-jie Sun, Hong-zhi Xu, Shou-yong Hun, Xiao-hui Sui & Ning-ning Shan. (2023) Identification of ORM1, vWF, SPARC, and PPBP as immune-related proteins involved in immune thrombocytopenia by quantitative LC-MS/MS. Clinical Proteomics 20:1.
Crossref
Crossref
Alexandra Schifferli, Axel Rüfer, Alicia Rovo, Falk Nimmerjahn, Nathan Cantoni, Andreas Holbro, Geneviève Favre, Jan Dirks, Anna Wieland, Heike Faeth, Renata Pereira & Thomas Kühne. (2023)
Immunomodulation with romiplostim as a second‐line strategy in primary immune thrombocytopenia: The
iROM
study
. British Journal of Haematology 203:1, pages 119-130.
Crossref
Crossref
Mihaela Andreescu. (2023) The link between immune thrombocytopenia and the cytokine profile: a bridge to new therapeutical targets. Frontiers in Hematology 2.
Crossref
Crossref
Shimrit Ringelstein‐Harlev, Mona Fanadka, Netanel A. Horowitz, Noam P. Bettman & Tami Katz. (2022) In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T‐cell inhibitory properties, contributing to immunosuppression. European Journal of Haematology 110:4, pages 371-378.
Crossref
Crossref
Fady Mohamed El-Gendy, Amira M.F. Shehata, Esam Awad Abd El-Kawy & Mahmoud Ahmed El-Hawy. (2023) Changes and correlations of T-cell coinhibitory molecule programmed death-1 and interferon-γ in pediatric immune thrombocytopenia. Clinical and Experimental Pediatrics 66:3, pages 127-133.
Crossref
Crossref
Alessandro Allegra, Nicola Cicero, Giuseppe Mirabile, Concetto Mario Giorgianni & Sebastiano Gangemi. (2023) Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia. International Journal of Molecular Sciences 24:5, pages 4438.
Crossref
Crossref
Xiaojing Li, Wenwei Zhu, Jizhang Bao, Jiekai Li & Yongming Zhou. (2023) Efficacy and safety of cyclosporine-based regimens for primary immune thrombocytopenia: a systematic review and meta-analysis. Journal of International Medical Research 51:1, pages 030006052211498.
Crossref
Crossref
Jiao Ge & Yan Liu. (2022) Heat shock protein-70 is elevated in childhood primary immune thrombocytopenia. European Journal of Medical Research 27:1.
Crossref
Crossref
Hongyun Liu, Xiaoyan Liu, Guoyang Zhang, Jieyu Wang, Duolan Naren, Shuangfeng Xie, Yiqing Li, Danian Nie, Zhixiong Li & Liping Ma. (2022) The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients. Thrombosis Research 218, pages 157-168.
Crossref
Crossref
Ding-Ping Chen, Wei-Tzu Lin, Ying-Hao Wen & Wei-Ting Wang. (2022) Investigation of the correlation between immune thrombocytopenia and T cell activity-regulated gene polymorphism using functional study. Scientific Reports 12:1.
Crossref
Crossref
Xiaofei Ni, Daqi Li, Chenglu Yuan, Yafei Yu, Haoyi Wang, Lingjun Wang, Tianshu Yu, Ping Qin, Jun Peng, Ming Hou, Yan Shi & Yu Hou. (2022)
Single‐dose versus low‐dose rituximab in corticosteroid‐resistant or relapsed
ITP
: A multicenter, randomized, controlled study
. American Journal of Hematology 97:4, pages 440-447.
Crossref
Crossref
Claudia Cristina Tărniceriu, Loredana Liliana Hurjui, Irina Daniela Florea, Ion Hurjui, Irina Gradinaru, Daniela Maria Tanase, Carmen Delianu, Anca Haisan & Ludmila Lozneanu. (2022) Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms. Medicina 58:2, pages 211.
Crossref
Crossref
Paola Andrea Sacristán Rodríguez, Sandra Milena Sánchez Gutiérrez & Leonardo Bonilla Cortés. (2021) Trombocitopenia inmune primaria refractaria en el embarazo. A propósito de un caso. Revista Med 29:1, pages 105-109.
Crossref
Crossref
Tian-shu YuHao-yi WangYa-jing ZhaoYa-fei Yu, Yu Hou, Shuang LiuPan-pan HanXiao-fei NiXue-bin JiJun Peng, Xin-guang LiuMing Hou. (2021) Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia. Blood Advances 5:20, pages 4087-4101.
Crossref
Crossref
Yunqi Sun, Yu Hou, Guiyue Meng, Panpan Han, Yajing Zhao, Haoyi Wang, Miao Xu, Yawen Wang, Jihua Qiu, Jun Peng, Linlin Shao, Lu Sun & Ming Hou. (2021) Proteomic analysis and microRNA expression profiling of plasma‐derived exosomes in primary immune thrombocytopenia. British Journal of Haematology 194:6, pages 1045-1052.
Crossref
Crossref
Maria L. Lozano, Cristina Segú-Vergés, Mireia Coma, María T. Álvarez-Roman, José R. González-Porras, Laura Gutiérrez, David Valcárcel & Nora Butta. (2021) Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach. International Journal of Molecular Sciences 22:13, pages 6907.
Crossref
Crossref
Dina G. Elsaied, Nashwa M. Noreldin, Mohamed A. Saad, Mervat A. Elkhatteb & Noha E. Esheba. (2021) Myeloid-derived suppressor cells anticipate sustained treatment response in newly-diagnosed and persistent primary immune thrombocytopenia. Blood Cells, Molecules, and Diseases 87, pages 102529.
Crossref
Crossref
Gizem Yassa, Abdur R Shakir, Kuppuswamy Jagarlamudi & Ahmet E Yassa. (2020) Successful treatment of refractory secondary immune thrombocytopenia (antiphospholipid antibody syndrome-associated) with the combination of rituximab and romiplostim at the cost of severe bone pain: A case report and review of literature. Journal of Oncology Pharmacy Practice 27:1, pages 253-257.
Crossref
Crossref
Muhammad Hafiz Kamarul Bahrin, Harini Vijayenthiran, Laura Stimson & Humayun Ahmad. (2020) Persistent Immune Thrombocytopenia Resistant to Immunosuppressive Therapy: What Is the Way Forward?. Cureus.
Crossref
Crossref
Charlotta Ekstrand, Shahram Bahmanyar, Honar Cherif, Helle Kieler & Marie Linder. (2020) Cancer risk in patients with primary immune thrombocytopenia – A Swedish nationwide register study. Cancer Epidemiology 69, pages 101806.
Crossref
Crossref
Masaki Iino, Yuma Sakamoto & Tomoya Sato. (2020) Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice. International Journal of Hematology 112:2, pages 159-168.
Crossref
Crossref
Ju Li, Mingqiang Hua, Xiang Hu, Yanqi Zhang, Qi Feng, Jihua Qiu, Linlin Shao, Nailin Li, Ming Hou & Jun Peng. (2020) Dexamethasone suppresses the Th17/1 cell polarization in the CD4+ T cells from patients with primary immune thrombocytopenia. Thrombosis Research 190, pages 26-34.
Crossref
Crossref
Shih‐Chung Wang, Kuender D. Yang, Ching‐Yuang Lin, Alex Y. Huang, Chien‐Chou Hsiao, Ming‐Tsan Lin & Yi‐Giien Tsai. (2019) Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia. Pediatric Blood & Cancer 67:2.
Crossref
Crossref
Maura Argenziano, Chiara Tortora, Giulia Bellini, Alessandra Di Paola, Francesca Punzo & Francesca Rossi. (2019) The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases. International Journal of Molecular Sciences 20:23, pages 5875.
Crossref
Crossref
Alfred Balch, Jacob Wilkes, Emily Thorell, Andrew Pavia, Catherine M.T. Sherwin & Elena Y. Enioutina. (2019) Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals. International Immunopharmacology 76, pages 105868.
Crossref
Crossref
Emine E. Yalinbaş, Melike Sezgin Evim, Özcan Bör & Zafer Gülbaş. (2019) Cytokine Profile, Apoptosis, Glucocorticoid Receptor, and P-glycoprotein Expression Before and After Megadose Methylprednisolone Treatment in Children With Acute Immune Thrombocytopenia. Journal of Pediatric Hematology/Oncology 41:7, pages 574-578.
Crossref
Crossref
Luya Cheng, Chanjuan Liu, Feng Li, Boting Wu, Zhihui Min, Pu Chen, Yanxia Zhan, Yang Ke, Fanli Hua, Ling Yuan, Lihua Sun, Hao Chen, Lili Ji & Yunfeng Cheng. (2019) The prediction value of Treg cell subtype alterations for glucocorticoid treatment in newly diagnosed primary immune thrombocytopenia patients. Thrombosis Research 181, pages 10-16.
Crossref
Crossref
Huanzhu Chen, Chun Lin, Zhiqiang Fan, Wenjun Yu, Manxiong Cao, Changwen Ke & Xiaoyang Jiao. (2019) Serum cytokines and clinical features in patients with fever and thrombocytopenia syndrome. Clinica Chimica Acta 494, pages 22-30.
Crossref
Crossref
Gang Li, Lan Gao, Rufei Ma, Wenqian Tian & Ling Mingzhi. (2019)
Associations between
FCGR
polymorphisms and immune thrombocytopenia: A meta‐analysis
. Scandinavian Journal of Immunology 89:5, pages e12758.
Crossref
Crossref
Veysi Asoglu, Elif G Umit & Muzaffer Demir. (2019) A biomarker and therapeutical target in immune thrombocytopenia: TNF receptor-associated factor 6. Biomarkers in Medicine 13:1, pages 27-31.
Crossref
Crossref
Bertrand Lioger, François Maillot, David Ternant, Christophe Passot, Gilles Paintaud & Theodora Bejan-Angoulvant. (2019) Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. The Journal of Pediatrics 204, pages 225-233.e8.
Crossref
Crossref
Hadi Goubran, Caroline Hart, Ibraheem Othman & Jerard Seghatchian. (2018) Flow cytometry and immune thrombocytopenic purpura. Transfusion and Apheresis Science 57:6, pages 800-803.
Crossref
Crossref
Yang Ke, Feng Li, Yanxia Zhan, Boting Wu, Shanhua Zou, Lili Ji, Zhihui Min, Jiayun Hou, Lihua Sun, Hao Chen & Yunfeng Cheng. (2018) Aberrant phosphorylation of signal transducer and activator of transcription 3 protein of the CD4+ T cells in patients with primary immune thrombocytopenia. Blood Coagulation & Fibrinolysis 29:5, pages 458-464.
Crossref
Crossref
Noha M. El Husseiny, Amira El Sobky, Ahmed M. Khalaf, Mohamed Fateen, Doaa M. El Demerdash, Heba Youssef, Marwa Salah, Sara El Sayed Abd El Ghany, Sherin El Husseiny & Mona Gamil. (2018) Chronic immune thrombocytopenia. Egyptian experience. Comparative Clinical Pathology 27:3, pages 735-739.
Crossref
Crossref
YiChan Zhang, TingTing Ma, Xuan Zhou, JunHao Chen & Juan Li. (2018) Circulating level of Th17 cells is associated with sensitivity to glucocorticoids in patients with immune thrombocytopenia. International Journal of Hematology 107:4, pages 442-450.
Crossref
Crossref
Thomas Kühne. 2018. Antibody Therapy. Antibody Therapy
277
287
.
Anne Zufferey, Rick Kapur & John Semple. (2017) Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP). Journal of Clinical Medicine 6:2, pages 16.
Crossref
Crossref